Clinical Trials Browser

Phase 1 × tisagenlecleucel × 1 year × Clear all

NCT06408194 2026-02-10

Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies

Phase 1 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05075603 2025-10-23

Relapsed/Refractory Large B-cell Lymphoma With NT-I7 Post-CD19 CAR T-cell Therapy

Phase 1 Completed

Lymphoma, Large B-Cell, Diffuse

NCT04419909 2025-07-02

Retreatment With CTL019/CTL119

Phase 1 Not yet recruiting

Lymphoma, B-Cell